Pacific Biosciences of California (MEX:PACB) Beta: N/A (As of Jun. 30, 2026)


MEX:PACB Pacific Biosciences of California Inc MEX:PACB
53 GF Score
Price MXN27.50
GF Value MXN27.00
! 8 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Pacific Biosciences of California's Beta is Not available.

Pacific Biosciences of California  (MEX:PACB) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Pacific Biosciences of California Beta Related Terms

Pacific Biosciences of California Beta Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Beta Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pacific Biosciences of California Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:PACB
53GF Score
Pacific Biosciences of California Inc MEX:PACB
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Pacific Biosciences of California (MEX:PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be overvalued. The current stock price of MXN27.50 is trading 1.9% above its estimated GF Value™ of MXN27.00.

Key valuation signals for MEX:PACB:

  • Beta: N/A
  • GF Value™: MXN27.00 vs. price of MXN27.50 (1.9% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MEX:PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacific Biosciences of California Business Description

Other Exchanges PACB:USAP09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score

Get the complete analysis for MEX:PACB

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN27.50
Price
MXN27.00
GF Value